Christine Cooper is a Neurology physician. OpenAlex indexes 29 publications with 273 citations (h-index 9).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
171 Ashley Ave
Charleston, SC 294258908
Telephone
843-792-1414Registry record last updated 13 Jun 2016.
Industry payments
7 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- ABBVIE INC.Program year202511 payments
- MDD US Operations, LLCProgram year20251 payment
- Biogen, Inc.Program year20241 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
93.9%Aromatic Amino Acid Decarboxylation Inhibitor41.9%Carbidopa-Levodopa56%Rytary29%Carbidopa-Levodopa Er15%Part D≥89 patientsBenzodiazepine6.7%Clonazepam100%Part D≥22 patients+ 13 more classes in this area
Cardiovascular
4.3%Beta blocker2.9%Propranolol Hcl Er66%Propranolol Hcl34%Part D<11 patientsalpha-Adrenergic Agonist1.4%Midodrine Hcl100%Part D<11 patientsMusculoskeletal
1.8%gamma-Aminobutyric Acid-ergic Agonist1.8%Baclofen100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Genotype–Phenotype Relations for the Dystonia-Parkinsonism Genes GLB1, SLC6A3, SLC30A10, SLC39A14, and PLA2G6: MDSGene Systematic Review
International Journal of Molecular Sciences
2025 - Does Right‐Hand Motor Impairment Affect Performance on Cognitive Testing in Parkinson's Disease?
Movement Disorders Clinical Practice
2025
Similar KOLs
Other experts from the same institution or the same specialty.
Atte Meretoja
University of Helsinki
Bruce Miller, MD
University of California, San Francisco (UCSF)
Dennis Selkoe, MD
Brigham and Women's Hospital
Ettore Beghi
Mario Negri Institute for Pharmacological Research
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”